Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708460 · ClinicalTrials.gov registry record · NA
Feasibility Study: Ulthera Treatment of the Buttocks and Thighs
A NA study of Skin Laxity, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 1
- Study location
NCT01708460: Completed NA study of Skin Laxity, sponsored by Ulthera.
NCT01708460 is a NA study of Skin Laxity that has completed, run by Ulthera. The registered enrollment target is 31 participants, below the 188-participant average among 10 other Skin Laxity trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01708460, a NA study of Skin Laxity, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 1
- Study location
Study Summary
Up to 30 subjects will be enrolled. Enrolled subjects will receive an Ulthera® treatment to one side of the body, treating the lateral buttock region. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
Primary Outcome
As determined by a masked, qualitative assessment of photographs at three months post-treatment compared to baseline.
Conditions Studied
Interventions
- DEVICE Ulthera System Treatment
Study Locations (1)
New York
- Skin Laser and Surgery Specialist of New York and New Jersey - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-07 |
| Phase | NA |
What the finished NCT01708460 record still lists
NCT01708460 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 188-participant average among 10 other Skin Laxity trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Ulthera System Treatment is the first listed.
NCT01708460 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01708460 about?
NCT01708460 is a clinical study titled "Feasibility Study: Ulthera Treatment of the Buttocks and Thighs". Up to 30 subjects will be enrolled. Enrolled subjects will receive an Ulthera® treatment to one side of the body, treating the lateral buttock region. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each f...
What is the current status of trial NCT01708460?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-12. Estimated completion is 2013-07.
What conditions does trial NCT01708460 study?
This clinical trial studies the following conditions: Skin Laxity.
What interventions are being tested in trial NCT01708460?
The interventions under investigation include: Ulthera System Treatment (DEVICE).
Who is sponsoring clinical trial NCT01708460?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01708460 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01708460's enrollment target sits among peer trials
31 7th of 10 higher than 4 of 10 other Skin Laxity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Laxity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive Imaging
RECRUITING · NA
-
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
RECRUITING · NA
-
Evaluation of Fractional Ablative Laser Treatment for Skin Conditions
RECRUITING · NA
-
AV-23-001 AVAVA MIRIA Pilot Study
ACTIVE NOT RECRUITING · NA
-
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
ACTIVE NOT RECRUITING · NA
-
Evaluation of the Effects of a Biostimulator and Dermal Fillers for Cheek Augmentation and Contour Deficiencies
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia